Evidence map›Paper›PMID 28445510›Full record

ArticlePloS one2017

Whole genome re-sequencing to identify suppressor mutations of mutant and foreign Escherichia coli FtsZ.

Kiani A J Arkus Gardner, Masaki Osawa, Harold P Erickson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Comparative genomic analysis of multidrug-resistantInfection and drug resistance · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kiani A J Arkus GardnerDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
Masaki OsawaDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
Harold P EricksonDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina, United States of America.ORCID http://orcid.org/0000-0002-9104-8987
Duke Medical Center · US

Funding

Structure and Assembly Dynamics of FtsZR01GM066014 · NIGMS · DUKE UNIVERSITY · PI ERICKSON, HAROLD P · 2002 to 2018
$7.5M
A genomic and structural study of FtsZ constriction in cell divisionF31GM090677 · NIGMS · DUKE UNIVERSITY · PI GARDNER, KIANI ANELA JENIAH ARKUS · 2010 to 2012
$90k
NIGMS NIH HHS F31 GM090677NIGMS NIH HHS R01 GM066014
6 · The paper itself

Abstract

FtsZ is an essential protein for bacterial cell division, where it forms the cytoskeletal scaffold and may generate the constriction force. We have found previously that some mutant and foreign FtsZ that do not complement an ftsZ null can function for cell division in E. coli upon acquisition of a suppressor mutation somewhere in the genome. We have now identified, via whole genome re-sequencing, single nucleotide polymorphisms in 11 different suppressor strains. Most of the mutations are in genes of various metabolic pathways, which may modulate cell division indirectly. Mutations in three genes, ispA, accD and nlpI, may be more directly involved in cell division. In addition to the genomic suppressor mutations, we identified intragenic suppressors of three FtsZ point mutants (R174A, E250K and L272V).

Indexed as

Genome, BacterialBacterial ProteinsCytoskeletal ProteinsDNA, BacterialEscherichia coliEscherichia coli ProteinsHigh-Throughput Nucleotide SequencingMutationPlasmidsSequence AlignmentSequence Analysis, DNASuppression, GeneticBacterial ProteinsCytoskeletal ProteinsDNA, BacterialEscherichia coli ProteinsFtsZ protein, Bacteria

Identifiers

PMID28445510
PMCPMC5405962
OpenAlexW2609604196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.